Literature DB >> 15480768

Nodal peripheral T-cell lymphomas and, in particular, their lymphoepithelioid (Lennert's) variant are often derived from CD8(+) cytotoxic T-cells.

Eva Geissinger1, Tobias Odenwald, Seung-Sook Lee, Irina Bonzheim, Sabine Roth, Peter Reimer, Martin Wilhelm, Hans Konrad Müller-Hermelink, Thomas Rüdiger.   

Abstract

Nodal peripheral T-cell lymphomas are not well understood, and most of them are classified in the "not otherwise specified group" (PTCL-NOS). Data on their normal cellular derivation are ambiguous. Most peripheral T-cell lymphomas are composed of tumor cells and a (sometimes dominant) reactive background, which also includes resting and activated T-lymphocytes. We defined the phenotype of the tumor cells in 101 PTCL-NOS based on their cytological atypia and using immunohistochemical double stains on paraffin sections with CD4/Ki67 and CD8/Ki67. The results were correlated to clinical presentation and outcome. Lineage could be defined in 98 cases (97%). Tumor cells were CD4(+) in 43 cases and CD8(+) in 38. These presented at a younger age but a higher clinical stage compared with the CD4(+) lymphomas. In 15 cases, the atypical cells were CD4(-)CD8(-); two cases were CD4(+)CD8(+). Of 17 lymphoepithelioid (Lennert's) lymphomas, 15 expressed CD8, one each was CD4(+) and CD4(-)CD8(-).

Entities:  

Mesh:

Year:  2004        PMID: 15480768     DOI: 10.1007/s00428-004-1077-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  49 in total

1.  Identification of a leukemic counterpart of the plasmacytoid dendritic cells.

Authors:  L Chaperot; N Bendriss; O Manches; R Gressin; M Maynadie; F Trimoreau; H Orfeuvre; B Corront; J Feuillard; J J Sotto; J C Bensa; F Brière; J Plumas; M C Jacob
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

2.  Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma.

Authors:  S M Ansell; T M Habermann; P J Kurtin; T E Witzig; M G Chen; C Y Li; D J Inwards; J P Colgan
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

3.  Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification.

Authors:  C Montalbán; G Obeso; A Gallego; J M Castrillo; C Bellas; C Rivas
Journal:  Histopathology       Date:  1993-04       Impact factor: 5.087

4.  Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology.

Authors:  P M Kluin; A Feller; P Gaulard; E S Jaffe; C J Meijer; H K Müller-Hermelink; S Pileri
Journal:  Histopathology       Date:  2001-03       Impact factor: 5.087

5.  Lennert's lymphoma: a variant of cytotoxic T-cell lymphoma?

Authors:  Y Yamashita; S Nakamura; Y Kagami; Y Hasegawa; H Kojima; T Nagasawa; N Mori
Journal:  Am J Surg Pathol       Date:  2000-12       Impact factor: 6.394

6.  Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.

Authors:  Y Kagami; R Suzuki; H Taji; Y Yatabe; T Takeuchi; S Maeda; E Kondo; M Kojima; T Motoori; Y Mizoguchi; M Okamoto; K Ohnishi; H Yamabe; M Seto; M Ogura; T Koshikawa; T Takahashi; S Kurita; Y Morishima; T Suchi; S Nakamura
Journal:  Am J Surg Pathol       Date:  1999-10       Impact factor: 6.394

7.  HTLV-I-positive and HTLV-I-negative peripheral T-cell lymphomas in Taiwan Chinese.

Authors:  L Y Shih; T T Kuo; P Dunn; S J Liaw
Journal:  Int J Cancer       Date:  1992-01-21       Impact factor: 7.396

Review 8.  Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?

Authors:  M A Shipp
Journal:  Blood       Date:  1994-03-01       Impact factor: 22.113

9.  Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.

Authors:  W Siegert; C Nerl; M Engelhard; G Brittinger; M Tiemann; R Parwaresch; R Heinz; D Huhn
Journal:  Br J Haematol       Date:  1994-07       Impact factor: 6.998

10.  Lymphoepithelioid lymphoma (Lennert's lymphoma) is a monoclonal proliferation of helper/inducer T cells.

Authors:  A C Feller; G H Griesser; T W Mak; K Lennert
Journal:  Blood       Date:  1986-09       Impact factor: 22.113

View more
  11 in total

1.  Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies.

Authors:  Eva Geissinger; Irina Bonzheim; László Krenács; Sabine Roth; Philipp Ströbel; German Ott; Peter Reimer; Martin Wilhelm; Hans Konrad Müller-Hermelink; Thomas Rüdiger
Journal:  J Mol Diagn       Date:  2005-10       Impact factor: 5.568

2.  Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma.

Authors:  Javeed Iqbal; Dennis D Weisenburger; Timothy C Greiner; Julie M Vose; Timothy McKeithan; Can Kucuk; Huimin Geng; Karen Deffenbacher; Lynette Smith; Karen Dybkaer; Shigeo Nakamura; Masao Seto; Jan Delabie; Francoise Berger; Florence Loong; Wing Y Au; Young-Hyeh Ko; Ivy Sng; James Olen Armitage; Wing C Chan
Journal:  Blood       Date:  2009-11-18       Impact factor: 22.113

Review 3.  Why does cytotoxic chemotherapy cure only some cancers?

Authors:  Philip Savage; Justin Stebbing; Mark Bower; Tim Crook
Journal:  Nat Clin Pract Oncol       Date:  2008-11-04

4.  [Lymphomas of the spleen].

Authors:  A Marx; H K Müller-Hermelink; M Hartmann; E Geissinger; A Zettl; P Adam; T Rüdiger
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

5.  Morphological variability of lymphohistiocytic variant of anaplastic large cell lymphoma (former lymphohistiocytic lymphoma according to the Kiel classification).

Authors:  Wolfram Klapper; Matthias Böhm; Reiner Siebert; Karl Lennert
Journal:  Virchows Arch       Date:  2008-05-14       Impact factor: 4.064

6.  Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified.

Authors:  Maja Ludvigsen; Martin Bjerregård Pedersen; Kristina Lystlund Lauridsen; Tim Svenstrup Poulsen; Stephen Jacques Hamilton-Dutoit; Søren Besenbacher; Knud Bendix; Michael Boe Møller; Peter Nørgaard; Francesco d'Amore; Bent Honoré
Journal:  Blood Adv       Date:  2018-10-09

Review 7.  Updates of Peripheral T Cell Lymphomas Based on the 2017 WHO Classification.

Authors:  Parwiz J Siaghani; Joo Y Song
Journal:  Curr Hematol Malig Rep       Date:  2018-02       Impact factor: 4.213

Review 8.  Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.

Authors:  C Agostinelli; P P Piccaluga; P Went; M Rossi; A Gazzola; S Righi; T Sista; C Campidelli; P L Zinzani; B Falini; S A Pileri
Journal:  J Clin Pathol       Date:  2008-08-28       Impact factor: 3.411

Review 9.  Second malignancies in Hodgkin's disease: A review of the literature and report of a case with a secondary Lennert's lymphoma.

Authors:  Ernst Jg Norval; Erich J Raubenheimer
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

10.  Cutaneous CD8+ Cytotoxic T-Cell Lymphoma Infiltrates: Clinicopathological Correlation and Outcome of 35 Cases.

Authors:  Marion Wobser; Theresa Reinartz; Sabine Roth; Matthias Goebeler; Andreas Rosenwald; Eva Geissinger
Journal:  Oncol Ther       Date:  2016-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.